Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
ETFs with ANAC as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|5.19%||PowerShares DWA Healthcare Momentum Portfolio (PTH)||+0.97 (2.22%)|
|0.63%||Vanguard Russell 2000 Growth ETF (VTWG)||+10.24 (11.34%)|
|0.49%||iShares Russell 2000 Growth ETF (IWO)||+14.91 (11.98%)|
|0.32%||Vanguard Russell 2000 ETF (VTWO)||+11.22 (13.66%)|
|0.24%||iShares Russell 2000 ETF (IWM)||+14.33 (13.98%)|
Company Description (as filed with the SEC)
We are a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from our boron chemistry platform. We believe that our expertise in boron chemistry enables us to design and synthesize compounds that interact with drug targets in novel ways and also address drug targets that have been historically difficult to treat with traditional carbon-based compounds. We have applied this expertise across a range of inflammatory, fungal and bacterial diseases that represent significant unmet medical needs. We believe that our first approved product and our product development candidates may offer significant improvements over the standard of care for diseases that represent large, well-defined commercial opportunities. Our first approved product, KERYDIN® (tavaborole) topical solution, 5%, is an oxaborole antifungal approved by the U.S. ... More ...
Where does ANAC fit in the risk graph?
|Annual EPS Est:||$-1.39|
|Quarterly EPS Est:||-0.38|